p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion

Journal of Cell Biology

Volumn 204, Issue 7, 2014, Pages 1191-1207

  Yamauchi, Shota ^a,f   Hou, Yan Yan ^a   Guo, Alvin Kunyao ^a,b   Hirata, Hiroaki ^a   Nakajima, Wataru ^c   Yip, Ai Kia ^d   Yu, Cheng han ^a   Harada, Ichiro ^e   Chiam, Keng Hwee ^a,d   Sawada, Yasuhiro ^a,b   Tanaka, Nobuyuki ^c   Kawauchi, Keiko ^a,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d BIOINFORMATICS INSTITUTE   (Singapore)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^f UNIVERSITY OF FUKUI   (Japan)

^g KONAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; RAS PROTEIN; SERINE PROTEINASE OMI;

ACTIN FILAMENT; ARTICLE; CELL INVASION; CELL TRANSFORMATION; CYTOSOL; DOWN REGULATION; ENZYME ACTIVATION; FOCAL ADHESION; LAMELLIPODIUM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ACTINS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CRK-ASSOCIATED SUBSTRATE PROTEIN; DOWN-REGULATION; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEOLYSIS; PSEUDOPODIA; RAS PROTEINS; SERINE ENDOPEPTIDASES; SINGLE-CELL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897553749     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201309107     Document Type: Article

References (54)

1. Akin, O., and R.D. Mullins. 2008. Capping protein increases the rate of actinbased motility by promoting filament nucleation by the Arp2/3 complex. Cell. 133:841-851. http://dx.doi.org/10.1016/j.cell.2008.04.011
2. Albini, A., Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. Kozlowski, and R.N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
3. Cabodi, S., M. del Pilar Camacho-Leal, P. Di Stefano, and P. Defilippi. 2010. Integrin signalling adaptors: not only figurants in the cancer story. Nat. Rev. Cancer. 10:858-870. http://dx.doi.org/10.1038/nrc2967
4. Campbell, P.M., and C.J. Der. 2004. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin. Cancer Biol. 14:105-114. http://dx.doi .org/10.1016/j.semcancer.2003.09.015
5. De Vos, K.J., V.J. Allan, A.J. Grierson, and M.P. Sheetz. 2005. Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr. Biol. 15:678-683. http://dx.doi.org/10.1016/j.cub .2005.02.064
6. Defilippi, P., P. Di Stefano, and S. Cabodi. 2006. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 16:257-263. http://dx.doi .org/10.1016/j.tcb.2006.03.003
7. Enoksson, M., J. Li, M.M. Ivancic, J.C. Timmer, E. Wildfang, A. Eroshkin, G.S. Salvesen, and W.A. Tao. 2007. Identification of proteolytic cleavage sites by quantitative proteomics. J. Proteome Res. 6:2850-2858. http://dx.doi .org/10.1021/pr0701052
8. Fantin, V.R., and P. Leder. 2006. Mitochondriotoxic compounds for cancer therapy. Oncogene. 25:4787-4797. http://dx.doi.org/10.1038/sj.onc.1209599
9. Gilmore, A.P., A.D. Metcalfe, L.H. Romer, and C.H. Streuli. 2000. Integrinmediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J. Cell Biol. 149:431-446. http://dx.doi.org/10.1083/jcb.149.2.431
10. Green, D.R., and G. Kroemer. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature. 458:1127-1130. http://dx.doi.org/10.1038/nature07986
11. Grethe, S., M.P. Ares, T. Andersson, and M.I. Pörn-Ares. 2004. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp. Cell Res. 298:632-642. http:// dx.doi.org/10.1016/j.yexcr.2004.05.007
12. Guo, W., and F.G. Giancotti. 2004. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5:816-826. http://dx.doi.org/10.1038/nrm1490
13. Hoshino, A., Y. Mita, Y. Okawa, M. Ariyoshi, E. Iwai-Kanai, T. Ueyama, K. Ikeda, T. Ogata, and S. Matoba. 2013. Cytosolic p53 inhibits Parkinmediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun. 4:2308. http://dx.doi.org/10.1038/ncomms3308
14. Hu, Y., W. Lu, G. Chen, P. Wang, Z. Chen, Y. Zhou, M. Ogasawara, D. Trachootham, L. Feng, H. Pelicano, et al. 2012. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res. 22:399-412. http://dx.doi .org/10.1038/cr.2011.145
15. Johansson, A.C., H. Appelqvist, C. Nilsson, K. Kågedal, K. Roberg, and K. Ollinger. 2010. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 15:527-540. http://dx.doi.org/10.1007/ s10495-009-0452-5
16. Kawauchi, K., K. Araki, K. Tobiume, and N. Tanaka. 2008. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat. Cell Biol. 10:611-618. http://dx.doi.org/10 .1038/ncb1724
17. Kawauchi, K., W.W. Tan, K. Araki, F.B. Abu Bakar, M. Kim, H. Fujita, H. Hirata, and Y. Sawada. 2012. p130Cas-dependent actin remodelling regulates myogenic differentiation. Biochem. J. 445:323-332. http://dx.doi .org/10.1042/BJ20112169
18. Keil, V.C., F. Funke, A. Zeug, D. Schild, and M. Müller. 2011. Ratiometric high-resolution imaging of JC-1 fluorescence reveals the subcellular heterogeneity of astrocytic mitochondria. Pflugers Arch. 462:693-708. http://dx.doi.org/10.1007/s00424-011-1012-8
19. Kiuchi, T., K. Ohashi, S. Kurita, and K. Mizuno. 2007. Cofilin promotes stimulus-induced lamellipodium formation by generating an abundant supply of actin monomers. J. Cell Biol. 177:465-476. http://dx.doi.org/10.1083/ jcb.200610005
20. Kong, J.Y., S.S. Klassen, and S.W. Rabkin. 2005. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol. Cell. Biochem. 278:39-51. http://dx.doi.org/10.1007/s11010-005-1979-6
21. Liu, Z., H. Li, M. Derouet, A. Berezkin, T. Sasazuki, S. Shirasawa, and K. Rosen. 2006. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/ HtrA2 into the cytoplasm. J. Biol. Chem. 281:14738-14747. http://dx.doi .org/10.1074/jbc.M508664200
22. Marabese, M., M. Mazzoletti, F. Vikhanskaya, and M. Broggini. 2008. HtrA2 enhances the apoptotic functions of p73 on bax. Cell Death Differ. 15:849-858. http://dx.doi.org/10.1038/cdd.2008.7
23. Martinou, J.C., and R.J. Youle. 2011. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell. 21:92-101. http:// dx.doi.org/10.1016/j.devcel.2011.06.017
24. Meek, D.W. 2009. Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer. 9:714-723.
25. Miyashita, T., and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:293-299. http://dx.doi .org/10.1016/0092-8674(95)90412-3
26. Moore, S.W., P. Roca-Cusachs, and M.P. Sheetz. 2010. Stretchy proteins on stretchy substrates: the important elements of integrin-mediated rigidity sensing. Dev. Cell. 19:194-206. http://dx.doi.org/10.1016/j.devcel.2010.07.018
27. Muller, P.A., K.H. Vousden, and J.C. Norman. 2011. p53 and its mutants in tumor cell migration and invasion. J. Cell Biol. 192:209-218. http:// dx.doi.org/10.1083/jcb.201009059
28. Nakano, K., and K.H. Vousden. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:683-694. http://dx.doi.org/10.1016/S1097-2765(01) 00214-3
29. O'Keefe, K., H. Li, and Y. Zhang. 2003. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. Mol. Cell. Biol. 23:6396-6405. http://dx.doi.org/10.1128/ MCB.23.18.6396-6405.2003
30. Olson, M.F., and E. Sahai. 2009. The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis. 26:273-287. http://dx.doi.org/10.1007/s10585-008-9174-2
31. Parsons, J.T., A.R. Horwitz, and M.A. Schwartz. 2010. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 11:633-643. http://dx.doi.org/10.1038/nrm2957
32. Pawlak, G., and D.M. Helfman. 2001. Cytoskeletal changes in cell transformation and tumorigenesis. Curr. Opin. Genet. Dev. 11:41-47. http://dx.doi .org/10.1016/S0959-437X(00)00154-4
33. Perumalsamy, L.R., M. Nagala, and A. Sarin. 2010. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival. Proc. Natl. Acad. Sci. USA. 107:6882-6887. http://dx.doi.org/10 .1073/pnas.0910060107
34. Petrie, R.J., and K.M. Yamada. 2012. At the leading edge of three-dimensional cell migration. J. Cell Sci. 125:5917-5926. http://dx.doi.org/10.1242/jcs .093732
35. Plun-Favreau, H., K. Klupsch, N. Moisoi, S. Gandhi, S. Kjaer, D. Frith, K. Harvey, E. Deas, R.J. Harvey, N. McDonald, et al. 2007. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9:1243-1252. http://dx.doi.org/10.1038/ncb1644
36. Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H. Yu, D. Neukirchen, M. Bista, F. Bradke, D. Jenne, T.A. Holak, Z. Werb, et al. 2008. Lifeact: a versatile marker to visualize F-actin. Nat. Methods. 5:605-607. http://dx.doi .org/10.1038/nmeth.1220
37. Rivlin, N., R. Brosh, M. Oren, and V. Rotter. 2011. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2:466-474. http://dx.doi.org/10.1177/ 1947601911408889
38. Sakai, R., A. Iwamatsu, N. Hirano, S. Ogawa, T. Tanaka, H. Mano, Y. Yazaki, and H. Hirai. 1994. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:3748-3756.
39. Sharma, A., and B.J. Mayer. 2008. Phosphorylation of p130Cas initiates Rac activation and membrane ruffling. BMC Cell Biol. 9:50. http://dx.doi.org/ 10.1186/1471-2121-9-50
40. Sherr, C.J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991. http://dx.doi.org/10.1101/gad.12.19.2984
41. Su, J., M. Muranjan, and J. Sap. 1999. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9:505-511. http://dx.doi.org/10.1016/ S0960-9822(99)80234-6
42. Suzuki, Y., Y. Imai, H. Nakayama, K. Takahashi, K. Takio, and R. Takahashi. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell. 8:613-621. http:// dx.doi.org/10.1016/S1097-2765(01)00341-0
43. Tait, S.W., and D.R. Green. 2010. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11:621-632. http://dx.doi.org/10.1038/nrm2952
44. Vande Walle, L., P. Van Damme, M. Lamkanfi, X. Saelens, J. Vandekerckhove, K. Gevaert, and P. Vandenabeele. 2007. Proteome-wide Identification of HtrA2/Omi Substrates. J. Proteome Res. 6:1006-1015. http://dx.doi.org/10 .1021/pr060510d
45. Vande Walle, L., M. Lamkanfi, and P. Vandenabeele. 2008. The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 15:453-460. http://dx.doi.org/10.1038/sj.cdd.4402291
46. Vaseva, A.V., and U.M. Moll. 2009. The mitochondrial p53 pathway. Biochim. Biophys. Acta. 1787:414-420. http://dx.doi.org/10.1016/j.bbabio.2008.10.005
47. Vaseva, A.V., N.D. Marchenko, K. Ji, S.E. Tsirka, S. Holzmann, and U.M. Moll. 2012. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell. 149:1536-1548. http://dx.doi.org/10.1016/j.cell .2012.05.014
48. Vousden, K.H., and D.P. Lane. 2007. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8:275-283. http://dx.doi.org/10.1038/nrm2147
49. Vuori, K., and E. Ruoslahti. 1995. Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J. Biol. Chem. 270:22259-22262. http://dx.doi.org/10.1074/ jbc.270.38.22259
50. Wang, Y., and M.A. McNiven. 2012. Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J. Cell Biol. 196:375-385. http://dx.doi.org/10.1083/jcb.201105153
51. Westermann, B. 2010. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11:872-884. http://dx.doi.org/10.1038/nrm3013
52. Yamasaki, S., N. Yagishita, T. Sasaki, M. Nakazawa, Y. Kato, T. Yamadera, E. Bae, S. Toriyama, R. Ikeda, L. Zhang, et al. 2007. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 26:113-122. http://dx.doi.org/10.1038/sj.emboj.7601490
53. Yip, A.K., K. Iwasaki, C. Ursekar, H. Machiyama, M. Saxena, H. Chen, I. Harada, K.H. Chiam, and Y. Sawada. 2013. Cellular response to substrate rigidity is governed by either stress or strain. Biophys. J. 104:19-29. http://dx.doi.org/10.1016/j.bpj.2012.11.3805
54. Zheng, Y., Y. Xia, D. Hawke, M. Halle, M.L. Tremblay, X. Gao, X.Z. Zhou, K. Aldape, M.H. Cobb, K. Xie, et al. 2009. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol. Cell. 35:11-25. http://dx.doi.org/10.1016/j .molcel.2009.06.013